Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
22M
-
Shares change
-
+3.36M
-
Total reported value, excl. options
-
$316M
-
Value change
-
+$48.2M
-
Number of buys
-
44
-
Number of sells
-
-10
-
Price
-
$14.35
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q4 2019
63 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q4 2019.
Replimune Group, Inc. - COMMON STOCK (REPL) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22M shares
of 78.4M outstanding shares and own 28.1% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (5.32M shares), Bain Capital Life Sciences Investors, LLC (2.84M shares), Redmile Group, LLC (2.77M shares), BVF INC/IL (2.31M shares), BlackRock Inc. (934K shares), FMR LLC (868K shares), VANGUARD GROUP INC (800K shares), EMERALD ADVISERS, LLC (794K shares), EMERALD MUTUAL FUND ADVISERS TRUST (786K shares), and Artal Group S.A. (600K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.